Glutamine supplementation in preterm infants receiving parenteral nutrition leads to an early improvement in liver

Ying Wang1, Wei Cai, Ye-Xuan Tao

  • 1Department of Clinical Nutrition, Xin Hua Hospital, Kongjiang Road 1665, Shanghai 200092, China. caiw204@yahoo.com.cn.

Insights

Parenteral glutamine supplementation may protect premature infants from liver injury caused by parenteral nutrition. This nutritional support showed early hepatoprotective effects, reducing liver enzymes within 7-14 days.

Area of Science:

  • Neonatalogy
  • Pediatric Gastroenterology
  • Nutritional Science

Background:

  • Parenteral nutrition (PN) is essential for premature infants but can lead to liver injury.
  • The duration of PN correlates with the severity of hepatic dysfunction.
  • Glutamine, an amino acid, plays a crucial role in intestinal and hepatic health.

Purpose of the Study:

  • To investigate the hepatoprotective effects of parenteral glutamine supplementation in premature infants.
  • To determine the timeline for observing these protective effects.

Main Methods:

  • A double-blind, randomized, controlled clinical trial was conducted.
  • Thirty premature infants received either standard PN or PN supplemented with glutamine.
  • Hepatic function markers (AST, GGT, AKP) and clinical outcomes were assessed.

Main Results:

  • Glutamine supplementation significantly decreased AST and GGT levels within 7-14 days.
  • Alkaline phosphatase (AKP) levels did not increase in the glutamine group, unlike the control group.
  • No significant differences were observed in overall PN duration, growth, or hospitalization length.

Conclusions:

  • Parenteral glutamine supplementation demonstrates a hepatoprotective effect in premature infants.
  • The benefits of glutamine supplementation on liver function become evident relatively quickly during PN.
  • This highlights glutamine as a potential therapeutic agent to mitigate PN-induced liver injury.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
975
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
414
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
2.0K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
2.0K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
3.1K